Novel mechanism for sudden infant death syndrome: Persistent late sodium current secondary to mutations in caveolin-3

Heart Rhythm

Volumn 4, Issue 2, 2007, Pages 161-166

  Cronk, Lisa B ^a   Ye, Bin ^b   Kaku, Toshihiko ^b   Tester, David J ^c   Vatta, Matteo ^d,e   Makielski, Jonathan C ^b   Ackerman, Michael J ^a,c,f  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TRIESTE   (Italy)

^f Mayo Clinic   (United States)

Author keywords

Caveolae; Caveolin; Genetics; Ion channels; Sudden death; Sudden infant death syndrome

Indexed keywords

CAVEOLIN 3; GENOMIC DNA; SODIUM CHANNEL;

ARTICLE; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC ENGINEERING; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; SODIUM CURRENT; SUDDEN INFANT DEATH SYNDROME;

CAVEOLIN 3; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; INFANT; LONG QT SYNDROME; MALE; MUTATION, MISSENSE; PHENOTYPE; POLYMERASE CHAIN REACTION; SODIUM CHANNELS; SUDDEN INFANT DEATH;

EID: 33846510967     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.11.030     Document Type: Article

References (33)

1. Krous H.F., Beckwith J.B., Byard R.W., Rognum T.O., Bajanowski T., Corey T., Cutz E., Hanzlick R., Keens T.G., and Mitchell E.A. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 114 (2004) 234-238
2. American Academy of Pediatrics AAP Task Force on Infant Positioning and SIDS. Positioning and SIDS. published erratum appears in Pediatrics 1992;90[2 Pt 1]:264. Pediatrics 89 (1992) 1120-1126
3. Willinger M., Hoffman H.J., and Hartford R.B. Infant sleep position and risk for sudden infant death syndrome: report of meeting held January 13 and 14, 1994, National Institutes of Health, Bethesda, MD. Pediatrics 93 (1994) 814-819
4. Gibson E., Cullen J.A., Spinner S., Rankin K., and Spitzer A.R. Infant sleep position following new AAP guidelines. American Academy of Pediatrics. Pediatrics 96 (1995) 69-72
5. Dwyer T., Ponsonby A.L., Blizzard L., Newman N.M., and Cochrane J.A. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA 273 (1995) 783-789
6. Martin J.A., Kochanek K.D., Strobino D.M., Guyer B., and MacDorman M.F. Annual summary of vital statistics-2003. Pediatrics 115 (2005) 619-634
7. Guntheroth W.G. Theories of cardiovascular causes in sudden infant death syndrome. J Am Coll Cardiol 14 (1989) 443-447
8. Schwartz P.J., Stramba-Badiale M., Segantini A., Austoni P., Bosi G., Giorgetti R., Grancini F., Marni E.D., Perticone F., Rosti D., and Salice P. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338 (1998) 1709-1714
9. Schwartz P.J., Priori S.G., Dumaine R., Napolitano C., Antzelevitch C., Stramba-Badiale M., Richard T.A., Berti M.R., and Bloise R. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 343 (2000) 262-267
10. Hunt C.E., and Hauck F.R. Sudden infant death syndrome. CMAJ 174 (2006) 1861-1869
11. Ackerman M.J., Siu B.L., Sturner W.Q., et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286 (2001) 2264-2269
12. Tester D.J., and Ackerman M.J. Sudden infant death syndrome: how significant are the cardiac channelopathies?. Cardiovasc Res 67 (2005) 388-396
13. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ. Prevalence of long QT syndrome gene variants in sudden infant death syndrome. Circulation 2007 (in press).
14. Ackerman M.J., and Clapham D.E. Ion channels-basic science and clinical disease. N Engl J Med 336 (1997) 1575-1586
15. Burke A., Creighton W., Mont E., et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 112 (2005) 798-802
16. Plant L.D., Bowers P.N., Liu Q.Y., et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 116 (2006) 430-435
17. Mohler P.J., Schott J.-J., Gramolini A.O., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
18. Vatta M., Ackerman M.J., Ye B., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114 (2006) 2104-2112
19. Ackerman M.J., Tester D.J., Jones G., Will M.K., Burrow C.R., and Curran M. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc 78 (2003) 1479-1487
20. Nagatomo T., Fan Z., Ye B., et al. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels. Am J Physiol 275 (1998) H2016-H2024
21. Bennett P.B., Yazawa K., Makita N., and George Jr. A.L. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376 (1995) 683-685
22. Yarbrough T.L., Lu T., Lee H.C., and Shibata E.F. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 90 (2002) 443-449
23. Head B.P., Patel H.H., Roth D.M., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 280 (2005) 31036-31044
24. Feron O., and Kelly R.A. Gaining respectability: membrane-delimited, caveolar-restricted activation of ion channels. Circ Res 90 (2002) 369-370
25. Abriel H., and Kass R.S. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med 15 (2005) 35-40
26. Galbiati F., Razani B., and Lisanti M.P. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 7 (2001) 435-441
27. Vorgerd M., Ricker K., Ziemssen F., et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57 (2001) 2273-2277
28. Minetti C., Sotgia F., Bruno C., et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18 (1998) 365-368
29. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 1373;54:1373-1376.
30. Tateyama M., Aoki M., Nishino I., et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy [published erratum appears in Neurology 2002;58:839]. published erratum appears in Neurology 2002;58:839. Neurology 58 (2002) 323-325
31. Ng W., and Lau C.P. Cardiac arrhythmias as presenting symptoms in patients with limb-girdle muscular dystrophy. Int J Cardiol 59 (1997) 157-160
32. van der Kooi A.J., de Voogt W.G., Barth P.G., et al. The heart in limb girdle muscular dystrophy. Heart 79 (1998) 73-77
33. Fulizio L., Chiara Nascimbeni A., Fanin M., et al. Molecular and muscle pathology in a series of caveolinopathy patients. Hum Mutat 25 (2005) 82-89